Holen Sie sich die Stockscreener-App
0.2964
1.23%
-0.0036
Handel nachbörslich:
.29
-0.0064
-2.16%
Schlusskurs vom Vortag:
$0.30
Offen:
$0.292
24-Stunden-Volumen:
655.49K
Relative Volume:
0.11
Marktkapitalisierung:
$16.79M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-27.04M
KGV:
-0.1501
EPS:
-1.9743
Netto-Cashflow:
$-17.53M
1W Leistung:
+6.58%
1M Leistung:
-5.91%
6M Leistung:
-85.55%
1J Leistung:
-95.94%
1-Tages-Spanne:
$0.29
$0.306
1-Wochen-Bereich:
$0.2722
$0.31
52-Wochen-Spanne:
$0.25
$7.73
Medicus Pharma Ltd Stock (MDCX) Company Profile
Firmenname
Medicus Pharma Ltd
Sektor
Telefon
610-540-7515
Adresse
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Compare MDCX vs LLY, JNJ, ABBV, MRK, AZN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
0.2964 | 17.00M | 0 | -27.04M | -17.53M | -1.9743 |
LLY
Lilly Eli Co
|
1,067.31 | 949.70B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
230.31 | 564.11B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
213.09 | 381.10B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
119.74 | 302.33B | 65.51B | 8.93B | 14.12B | 3.5532 |
AZN
Astrazeneca Plc
|
187.26 | 290.06B | 60.48B | 10.40B | 8.05B | 3.3297 |
Medicus Pharma Ltd Aktie (MDCX) Neueste Nachrichten
MDCX Should I Buy - Intellectia AI
Medicus Pharma Ltd (MDCX) Stock Price, Quote, News & History - Benzinga
Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony - Chillicothe Gazette
MDCX Stock Chart | MEDICUS PHARMA LTD (NASDAQ:MDCX) - ChartMill
New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast (NASDAQ:CAST), Stardust Power (NASDAQ:SDST), Lost Soldier Oil and Gas, Virtuix Holdings (NASDAQ:VTIX), and Medi - ACCESS Newswire
MDCX Stock Price, Quote & Chart | MEDICUS PHARMA LTD (NASDAQ:MDCX) - ChartMill
MDCX Technical Analysis | Trend, Signals & Chart Patterns | MEDICUS PHARMA LTD (NASDAQ:MDCX) - ChartMill
Medicus Pharma Ltd. (MDCXW) Reports FDA Progress and Expands 2026 Clinical Outlook - Insider Monkey
User - The Chronicle-Journal
Small cap wrap: Digi Power X, New Era Energy & Digital, 374Water, Medicus Pharma… - Proactive financial news
Medicus Pharma (Nasdaq: MDCX) Advances Lead Skin Cancer Regimen - MyChesCo
Medicus Pharma sees catalyst-rich year ahead as SkinJect and Teverelix progress - Yahoo Finance
MSN Money - MSN
Medicus Pharma 1Q Loss/Shr 31c >MDCX - Moomoo
Medicus Pharma Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Medicus Pharma (MDCX) registers 3.25M shares as warrants remain exercisable - Stock Titan
Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
Medicus Pharma Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Medicus Pharma (NASDAQ: MDCX) flags going concern as Q1 loss widens - Stock Titan
TradingKey - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
New to The Street Broadcasts Show #752 on Bloomberg Television Featuring Graphene Manufacturing Group (OTCQX:GMGRF), T-REX Acquisition Corp (NASDAQ:TRXA), KITON, and Roadzen (NASDAQ:RDZN) - Moomoo
Medicus Pharma Ltd expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Maxim Group Maintains Medicus Pharma(MDCX.US) With Buy Rating, Maintains Target Price $2 - Moomoo
Medicus Pharma Reports Expanded Phase 2 Skin Cancer Trial Data - MyChesCo
EXCLUSIVE: Medicus Sees Strongest Efficacy At Higher Dose In Skin Cancer Study - Sahm
Market movers: Uber, Super Micro Computer, Medicus Pharma, Arizona Gold & Silver, Hut 8... - Proactive financial news
Medicus Pharma reports strong Phase 2 dose response in skin cancer study - Proactive financial news
Medicus Pharma reports dose response data from skin cancer study By Investing.com - Investing.com India
Medicus Pharma reports dose response data from skin cancer study - Investing.com UK
Medicus Pharma highlights positive dose-response in updated skin cancer trial results - Yahoo Finance
$Medicus Pharma (MDCX.US)$ - Moomoo
Skin cancer study points to higher-dose winner with 55% response - Stock Titan
Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response - ChartMill
Ajay Raju and Togo PHL entities report 2.03M shares in Medicus Pharma (MDCX) - Stock Titan
Medicus Pharma Meets Lawmakers to Advance SkinJect Program - MyChesCo
[ARS] Medicus Pharma Ltd. SEC Filing - Stock Titan
Medicus reports Phase 2 basal cell carcinoma trial results By Investing.com - Investing.com India
Medicus Pharma (MDCX) plans up to 50-for-1 share consolidation to address Nasdaq bid-price rule - Stock Titan
MDCX SEC FilingsMedicus Pharma Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Medicus Pharma on Bloomberg World - Public Opinion
Medicus Pharma 2025 Executive Compensation, Board Governance, and Equity Incentive Plan Overview - Minichart
Medicus Pharma (Nasdaq: MDCX) details board structure and leadership pay - Stock Titan
Exclusive: Medicus Pharma refines trial design to cut costs, accelerate development for enlarged prostate patients - MSN
10-K/A: Annual report (Amendment) - Moomoo
MDCXW Price History for Medicus Pharma Ltd WT Stock - Barchart.com
Medicus Pharma lobbies Congress on SkinJect regulatory pathway for rare Gorlin syndrome - Yahoo! Finance Canada
Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill - The Manila Times
Finanzdaten der Medicus Pharma Ltd-Aktie (MDCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):